Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Cardiogenic shock in intensive medicine care: Are the “old scores” still useful?
Session:
Posters 5 - Écran 2 - Doença Coronária
Speaker:
Hugo Miranda
Congress:
CPC 2019
Topic:
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
Theme:
14. Acute Cardiac Care
Subtheme:
14.4 Acute Cardiac Care – Cardiogenic Shock
Session Type:
Posters
FP Number:
---
Authors:
Hugo Miranda; Igor Milet; Nélson Barros; Hélder Leite; Isabel Militão; Francisco Esteves
Abstract
<p><strong>Introduction: </strong></p> <p>Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion due to primary cardiac dysfunction. Several clinical and biological factors have been used for prognosis assessment. Those factors have been recently regrouped into scores combining independent parameters—the Sleeper, CardShock and IABP-SHOCK II score, which aren’t used daily in general ICU.</p> <p> </p> <p><strong>Objectives:</strong></p> <p>Evaluate usefulness of SOFA, APACHE II and SAPS II scores in predicting the outcome in CS patients (P) and identify the most useful one, if applicable.</p> <p> </p> <p><strong>Methods: </strong></p> <p>Retrospective analysis of P admitted in our general Intensive Care Unit (ICU), with confirmed diagnosis of CS, within a period of 5 years. We analyzed common epidemiological variables, evolution during ICU stay, established therapeutics and outcome. We estimated SOFA, APACHE II and SAPS II score at admission and discharge, when applicable.</p> <p> </p> <p><strong>Results: </strong></p> <p>90 P were included. Mean age of 69,59 ± 12,23 years, with a predominance of males (56,7%). Admission SOFA of 10,39 ± 3,19. The main cause of CS was non-ischemic, with only 33,3% caused by acute coronary syndromes. 68,9% needed mechanical invasive ventilation in the first 24h, maximum PEEP used of 8,22±2,76. VCPVG was the most used ventilatory mode, with median weaning time of 3 days. PaO2/FiO2 ratio and lactactes at admission of 178,5 and 2,85, respectively. All the P needed aminergic support. Renal replacement therapy was used in 34,4% P. Step-up and step-down in ICU unit in 6,7 and 26,7% of the cases, respectively. Infectious intercurrence (nosocomial infection) in 35,51% cases. Limitation of the therapeutic effort in 42,22% P. </p> <p>At discharge, P presented median ICU stay of 5 days (hospital stay of 10,5 days) with SOFA, APACHE II and SAPS II of 7.6±5,06, 24,5 and 56,61 ± 19,71, respectively. Hospital mortality of 45,6%.</p> <p>We found a statistically significant association between outcome and: 1) admission SOFA (p=0,006), 2) APACHE II (p<0,001), 3) SAPS II (p< 0,001). We also point out that after applying a logistic regression only APACHE II (OR: 1,13; IC95%: 1,028-1,253) had relevant prediction power.</p> <p><strong>Conclusion</strong></p> <p>In our study, we found that APACHE II was the only score capable of predicting the outcome of our P. It provides an estimate of ICU mortality based on a number of laboratory values and patient signs taking both acute and chronic disease into account. </p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site